GALLANT 4 Tesaglitazar vs. Glibenclamide

Clinical trial NCT00255541 · TERMINATED

Trial details

NCT number: NCT00255541
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2004-09-01
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.